Cole Ryan reported AUPH

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002126966-26-000003

Machine-readable

Structured copy

Timestamps

Event (reported)

May 18, 2026

Published

May 20, 2026

Ingested by INSIDER

Nov 5, 03:57 UTC

Last re-read

Nov 5, 03:57 UTC

Extracted facts

Filer

Cole Ryan

Role

Chief Operating Officer

Transaction

Grant or awardAs filed: “A”

Asset

Aurinia Pharmaceuticals Inc.

Ticker

AUPH

Shares

116.1K

Price per share

$0

Execution date (reported)

May 18, 2026

Owned after transaction

116.1K shares

Days from execution to publication

2

What this establishes

Cole Ryan filed this Form 4 reporting a grant or award of AUPH on May 18, 2026. It became public on May 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Operating Officer

Cole Ryancik:0002126966

Issuer

Aurinia Pharmaceuticals Inc.cik:0001600620

Revision history · 0

No field has changed since this record was first ingested.